BARD1 | BRCA1 associated RING domain 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
BAZ1A | Bromodomain adjacent to zinc finger domain, 1A | Predicted intracellular proteins
| | | | | Expressed in all |
BAZ1B | Bromodomain adjacent to zinc finger domain, 1B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BBX | Bobby sox homolog (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BCAS1 | Breast carcinoma amplified sequence 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCAT2 | Branched chain amino-acid transaminase 2, mitochondrial | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BECN1 | Beclin 1, autophagy related | Predicted intracellular proteins
| | | | | Expressed in all |
BEND2 | BEN domain containing 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
BICD2 | Bicaudal D homolog 2 (Drosophila) | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BID | BH3 interacting domain death agonist | Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIN1 | Bridging integrator 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
BLMH | Bleomycin hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
BNIP1 | BCL2/adenovirus E1B 19kDa interacting protein 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BPGM | 2,3-bisphosphoglycerate mutase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BPHL | Biphenyl hydrolase-like (serine hydrolase) | Predicted intracellular proteins
| | | | | Expressed in all |
BPI | Bactericidal/permeability-increasing protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFA3 | BPI fold containing family A, member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
BRAP | BRCA1 associated protein | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BRD1 | Bromodomain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BRD8 | Bromodomain containing 8 | Predicted intracellular proteins
| | | | | Expressed in all |
BSDC1 | BSD domain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BSND | Barttin CLCNK-type chloride channel accessory beta subunit | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
BTF3 | Basic transcription factor 3 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BTLA | B and T lymphocyte associated | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
BUB3 | BUB3 mitotic checkpoint protein | Predicted intracellular proteins
| | | | | Expressed in all |
BYSL | Bystin-like | Predicted intracellular proteins
| | | | | Expressed in all |
C10orf126 | Chromosome 10 open reading frame 126 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C11orf54 | Chromosome 11 open reading frame 54 | Predicted intracellular proteins
| | | | | Expressed in all |
C12orf56 | Chromosome 12 open reading frame 56 | Predicted intracellular proteins
| | | | | Tissue enriched |
C14orf166 | Chromosome 14 open reading frame 166 | Predicted intracellular proteins
| | | | | Expressed in all |
C14orf2 | Chromosome 14 open reading frame 2 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C17orf64 | Chromosome 17 open reading frame 64 | Predicted intracellular proteins
| | | | | Tissue enriched |
C19orf10 | Chromosome 19 open reading frame 10 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |